104873-5 |
Glucose dumping syndrome panel |
- |
Ser/Plas/Bld |
Pt |
- |
|
|
ACTIVE |
Glucose dumping syndrome panel - Serum, Plasma or Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEM/BC |
|
104873-5 |
|
|
|
|
Order |
|
|
|
0 |
GDS pnl SerPlBld |
|
|
|
N |
|
Blood; GDS pnl; Glu; Gluc; Glucoseur; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pl; PlasBld; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
104874-3 |
Erythrocyte/Specimen Volume^Baseline |
VFr |
Bld |
Pt |
Qn |
Calculated |
|
ACTIVE |
Hematocrit [Volume Fraction] of Blood by calculation --baseline |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
104874-3 |
|
Calculated |
|
|
Both |
|
|
|
0 |
Hct BS VFr Bld Calc |
|
|
|
N |
|
Blood; BS; Calc; Calculation; Discocyte; Erc; Erythrocytes; HEMATOLOGY/CELL COUNTS; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Spec; Vol; Volfr; Volume fraction; WB; Whole blood |
2.79 |
2.78 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT:Hematocrit as a component is not an adequate description for a ratio, therefore Hematocrit is kept as a synonym, and the actual component is expressed as it should be:Erythrocyte/Specimen Volume; |
0 |
104875-0 |
Hematocrit^30M post dose glucose |
VFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Hematocrit [Volume Fraction] of Blood --30 minutes post dose glucose |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
104875-0 |
|
|
|
|
Both |
|
|
|
0 |
Hct 30M p Glc VFr Bld |
|
|
|
N |
|
30M p Glc; After; Blood; Glu; Gluc; Glucoseur; Hct; Hematocrit^30M post glu; HEMATOLOGY/CELL COUNTS; p dose; p Glc; PCV; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
104876-8 |
Hematocrit^1H post dose glucose |
VFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Hematocrit [Volume Fraction] of Blood --1 hour post dose glucose |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
104876-8 |
|
|
|
|
Both |
|
|
|
0 |
Hct 1h p Glc VFr Bld |
|
|
|
N |
|
1 hour; 1.0Hr; 1h p Glc; 60 min; 60 minutes; 60M; 60min; After; Blood; Glu; Gluc; Glucoseur; Hct; Hct 1h p Glc; HEMATOLOGY/CELL COUNTS; p dose; p Glc; PCV; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
104877-6 |
Hematocrit^1.5H post dose glucose |
VFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Hematocrit [Volume Fraction] of Blood --1.5 hours post dose glucose |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
104877-6 |
|
|
|
|
Both |
|
|
|
0 |
Hct 1.5h p Glc VFr Bld |
|
|
|
N |
|
1 1/2 hours; 1 1/2 HR; 1.5h p Glc; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Blood; Glu; Gluc; Glucoseur; Hct; Hct 1.5h p Glc; HEMATOLOGY/CELL COUNTS; p dose; p Glc; PCV; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
104878-4 |
Hematocrit^2H post dose glucose |
VFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Hematocrit [Volume Fraction] of Blood --2 hours post dose glucose |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
104878-4 |
|
|
|
|
Both |
|
|
|
0 |
Hct 2h p Glc VFr Bld |
|
|
|
N |
|
120 min; 120 minutes; 120min; 2 hours; 2h p Glc; After; Blood; Glu; Gluc; Glucoseur; Hct; Hct 2h p Glc; HEMATOLOGY/CELL COUNTS; p dose; p Glc; PCV; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
104879-2 |
Hematocrit^2.5H post dose glucose |
VFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Hematocrit [Volume Fraction] of Blood --2.5 hours post dose glucose |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
104879-2 |
|
|
|
|
Both |
|
|
|
0 |
Hct 2.5h p Glc VFr Bld |
|
|
|
N |
|
2.5h p Glc; After; Blood; Glu; Gluc; Glucoseur; Hct; Hct 2.5h p Glc; HEMATOLOGY/CELL COUNTS; p dose; p Glc; PCV; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
10488-5 |
IgA Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
IgA Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
10488-5 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
IgA Ag Tiss Ql ImStn |
|
|
|
|
|
Antigen; Antigens; IHC; Imm; Immune globulin A; Immunoglobulin A; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.73 |
1.0i |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
104880-0 |
Hematocrit^3H post dose glucose |
VFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Hematocrit [Volume Fraction] of Blood --3 hours post dose glucose |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
104880-0 |
|
|
|
|
Both |
|
|
|
0 |
Hct 3h p Glc VFr Bld |
|
|
|
N |
|
3h p Glc; After; Blood; Glu; Gluc; Glucoseur; Hct; Hct 3h p Glc; HEMATOLOGY/CELL COUNTS; p dose; p Glc; PCV; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
104881-8 |
Equine acute pain scale |
Imp |
^Animal |
Pt |
Ord |
|
|
ACTIVE |
Equine acute pain scale Animal |
|
ADD |
DefinitionDescription |
|
|
|
|
�© 2006 PW Hellyer, SR Uhrig, NG Robinson. Used with permission. |
|
|
|
|
CLIN.VET |
|
104881-8 |
|
|
|
|
Both |
|
|
|
0 |
Equine acute pain scale Animal |
|
|
Equine acute pain scale |
N |
|
CLIN; CLIN.VET; Equin; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen |
2.78 |
2.78 |
|
|
|
|
�© 2006 PW Hellyer, SR Uhrig, NG Robinson. Used with permission. |
|
|
|
|
|
|
0 |
104882-6 |
Feline acute pain scale |
Imp |
^Animal |
Pt |
Ord |
|
|
ACTIVE |
Feline acute pain scale Animal |
|
ADD |
DefinitionDescription |
|
|
|
|
�© 2006 PW Hellyer, SR Uhrig, NG Robinson. Used with permission. |
|
|
|
|
CLIN.VET |
|
104882-6 |
|
|
|
|
Both |
|
|
|
0 |
Feline acute pain scale Animal |
|
|
|
N |
|
CLIN; CLIN.VET; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen |
2.78 |
2.78 |
|
|
|
|
�© 2006 PW Hellyer, SR Uhrig, NG Robinson. Used with permission. |
|
|
|
|
|
|
0 |
104883-4 |
Phosphorus.reabsorbed by renal tubules/Phosphorus.total filtered |
RelRto |
Urine+Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Phosphorus.reabsorbed by renal tubules/Phosphorus.total filtered in Urine and Serum or Plasma Qualitative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
TRP = [ 1- (urine conc PO4 x plasma conc Crea ) / (Plasma conc PO4 x urine conc Crea) ] x 100 |
|
|
|
CHEM |
|
104883-4 |
|
|
|
|
Both |
|
|
|
0 |
Pho.resorb rnl tub/Pho.ttl fil |
|
|
|
N |
|
Chemistry; Kidney; Ordinal; Pho.reabsorb renal tubules; Pho.reabsorb tubules/Pho.total filtered; Pho.total filtered; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Relative ratio; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl; UA; UR; Ur+SerPl; Urn |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104884-2 |
Tubular reabsorption of phosphorus panel |
- |
Urine+Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Tubular reabsorption of phosphorus panel - Urine and Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
104884-2 |
|
|
|
|
Order |
|
|
|
0 |
Tubular reabsorp phos pnl Ur+SerPl |
|
|
|
N |
|
Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TmP; Tubular reabsorp phos pnl; UA; UR; Ur+SerPl; Urn |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
104886-7 |
Remission status |
Find |
^Patient |
Pt |
Nar |
|
|
ACTIVE |
Remission status Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN |
|
104886-7 |
|
|
|
|
Observation |
|
|
|
0 |
Remission status |
|
|
|
N |
|
ADMIN; Finding; Findings; Narrative; Point in time; Random; Report |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104887-5 |
Problem occurrence |
Find |
^Patient |
Pt |
Nar |
|
|
ACTIVE |
Problem occurrence Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN |
|
104887-5 |
|
|
|
|
Observation |
|
|
|
0 |
Problem occurrence |
|
|
|
N |
|
ADMIN; Finding; Findings; Narrative; Point in time; Random; Report |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104888-3 |
Duration of reaction |
Time |
^Patient |
Pt |
Qn |
|
|
ACTIVE |
Duration of reaction |
|
ADD |
DefinitionDescription |
|
|
min |
|
|
|
|
|
|
ADMIN |
|
104888-3 |
|
|
|
|
Observation |
|
|
|
0 |
Duration of reaction |
|
|
|
N |
|
ADMIN; Durat; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn |
2.78 |
2.78 |
|
|
|
|
|
|
|
min |
|
|
|
0 |
104889-1 |
Admission reason |
Find |
^Patient |
Pt |
Nar |
|
|
ACTIVE |
Admission reason Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN |
|
104889-1 |
|
|
|
|
Observation |
|
|
|
0 |
Admission reason |
|
|
|
N |
|
ADMIN; Finding; Findings; Narrative; Point in time; Random; Report |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
10489-3 |
IgA.heavy chain Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
IgA.heavy chain Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
10489-3 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
IgA HC Ag Tiss Ql ImStn |
|
|
|
|
|
Antigen; Antigens; Chains; Chn; IgA HC; IHC; Imm; Immune globulin A; Immunoglobulin A; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.56 |
1.0i |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
104890-9 |
Nationality |
Find |
Person |
Pt |
Nar |
|
|
ACTIVE |
Nationality Person Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN |
|
104890-9 |
|
|
|
|
Observation |
|
|
|
0 |
Nationality Person |
|
|
|
N |
|
^Person; ADMIN; Finding; Findings; Narrative; Persons; Point in time; Random; Report |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104891-7 |
Communication aid |
Find |
Person |
Pt |
Nar |
|
|
ACTIVE |
Communication aid Person Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN |
|
104891-7 |
|
|
|
|
Observation |
|
|
|
0 |
Communication aid Person |
|
|
|
N |
|
^Person; ADMIN; Finding; Findings; Narrative; Persons; Point in time; Random; Report |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104892-5 |
Number of potentially affected by condition |
Num |
^Family member |
Pt |
Qn |
|
|
ACTIVE |
Number of potentially affected by condition Family member |
|
ADD |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
ADMIN |
|
104892-5 |
|
|
|
|
Observation |
|
|
|
0 |
# of potentially affctd by condit |
|
|
|
N |
|
ADMIN; Cnt; Count; Fam Mem; No; Num; Num of potentially aff by cndtn; Number; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.78 |
2.78 |
|
|
|
|
|
|
|
{#} |
|
|
|
0 |
104893-3 |
Information updated date and time |
TmStp |
^Patient |
Pt |
Qn |
|
|
ACTIVE |
Information updated date and time |
|
ADD |
DefinitionDescription |
|
|
{mm/dd/yyyy} |
|
|
|
|
|
|
ADMIN |
|
104893-3 |
|
|
|
|
Observation |
|
|
|
0 |
Information updated date and time |
|
|
|
N |
|
ADMIN; Date and time; Date+time; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp |
2.78 |
2.78 |
|
|
|
|
|
|
|
{mm/dd/yyyy} |
|
|
|
0 |
104894-1 |
Genetic predisposition indicator |
Find |
Person |
Pt |
Nar |
|
|
ACTIVE |
Genetic predisposition indicator Person Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN |
|
104894-1 |
|
|
|
|
Observation |
|
|
|
0 |
Genetic predisposition indicator Person |
|
|
|
N |
|
^Person; ADMIN; Finding; Findings; Genetics; Genomic; Narrative; Persons; Point in time; Random; Report |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104895-8 |
Problem related issues |
Find |
^Patient |
Pt |
Nar |
|
|
ACTIVE |
Problem related issues Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN |
|
104895-8 |
|
|
|
|
Observation |
|
|
|
0 |
Problem related issues |
|
|
|
N |
|
ADMIN; Finding; Findings; Narrative; Point in time; Random; Report |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104896-6 |
Resolution phase |
Find |
^Patient |
Pt |
Nar |
|
|
ACTIVE |
Resolution phase Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN |
|
104896-6 |
|
|
|
|
Observation |
|
|
|
0 |
Resolution phase |
|
|
|
N |
|
ADMIN; Finding; Findings; Narrative; Point in time; Random; Report |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |